Factors contributing to the development of anaemia in Plasmodium falciparum malaria: what about drug-resistant parasites?
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Factors contributing to the development of anaemia in Plasmodium falciparum malaria: what about drug-resistant parasites? / Quashie, Neils Ben; Akanmori, Bartholomew D; Ofori-Adjei, David; Goka, Bamenla Q; Kurtzhals, Jørgen.
In: Journal of Tropical Pediatrics, Vol. 52, No. 4, 2006, p. 254-9.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Factors contributing to the development of anaemia in Plasmodium falciparum malaria: what about drug-resistant parasites?
AU - Quashie, Neils Ben
AU - Akanmori, Bartholomew D
AU - Ofori-Adjei, David
AU - Goka, Bamenla Q
AU - Kurtzhals, Jørgen
N1 - Keywords: Amodiaquine; Anemia; Animals; Artemisinins; Child; Child, Preschool; Chloroquine; Drug Resistance; Drug Therapy, Combination; Humans; Infant; Malaria; Plasmodium falciparum; Sesquiterpenes
PY - 2006
Y1 - 2006
N2 - A major manifestation of complicated malaria especially among children is severe anaemia, the pathogenesis of which is not well understood. Among other factors, suppression of the bone marrow's response to erythropoietin, which is rapidly reversed after successful treatment of the malaria, has been implicated in its pathogenesis. Since resolution of malaria restores erythropoiesis, we hypothesized that drug-resistant strains of Plasmodium falciparum would increase the risk of severe anaemia developing from initially uncomplicated malaria. Using both in vivo and in vitro drug-sensitivity tests we compared the prevalence of drug-resistant malaria between severe malarial anaemia SA and non-anaemic malaria NAM patients. Assessment of treatment outcome using the WHO in vivo criteria showed no significant difference in parasite resistance between the two groups. The mean parasite clearance time was also comparable. Treatment failures of about 14 per cent and 12 per cent were observed between SA and NAM patients respectively. The in vitro drug susceptibility test showed overall mean IC50 values of 0.41x10(-6) mol/l and 0.32x10(-6) mol/l blood for SA and NAM groups respectively. Geometric mean pre-treatment blood levels of chloroquine did not differ much between the two groups. Findings from this study could not therefore implicate drug-resistant parasites in the pathogenesis of severe malarial anaemia.
AB - A major manifestation of complicated malaria especially among children is severe anaemia, the pathogenesis of which is not well understood. Among other factors, suppression of the bone marrow's response to erythropoietin, which is rapidly reversed after successful treatment of the malaria, has been implicated in its pathogenesis. Since resolution of malaria restores erythropoiesis, we hypothesized that drug-resistant strains of Plasmodium falciparum would increase the risk of severe anaemia developing from initially uncomplicated malaria. Using both in vivo and in vitro drug-sensitivity tests we compared the prevalence of drug-resistant malaria between severe malarial anaemia SA and non-anaemic malaria NAM patients. Assessment of treatment outcome using the WHO in vivo criteria showed no significant difference in parasite resistance between the two groups. The mean parasite clearance time was also comparable. Treatment failures of about 14 per cent and 12 per cent were observed between SA and NAM patients respectively. The in vitro drug susceptibility test showed overall mean IC50 values of 0.41x10(-6) mol/l and 0.32x10(-6) mol/l blood for SA and NAM groups respectively. Geometric mean pre-treatment blood levels of chloroquine did not differ much between the two groups. Findings from this study could not therefore implicate drug-resistant parasites in the pathogenesis of severe malarial anaemia.
U2 - 10.1093/tropej/fmi110
DO - 10.1093/tropej/fmi110
M3 - Journal article
C2 - 16326751
VL - 52
SP - 254
EP - 259
JO - Journal of Tropical Pediatrics
JF - Journal of Tropical Pediatrics
SN - 0142-6338
IS - 4
ER -
ID: 17274342